Under hypoxic conditions, hypoxia-inducible factors (particularly HIF-1α) upregulate the expression of drug efflux pumps such as P-glycoprotein and multidrug resistance-associated proteins, which pump chemotherapeutic agents out of cancer cells, reducing intracellular drug accumulation and efficacy, thereby contributing to MDR 117. This evidence concerns the gene ABCB1 and cancer.